Page 129 - Fluorescence-guided cancer surgery

REFERENCES
1. Oncoline, www.oncoline.nl/epitheliaal- ovariumcarcinoom, Accessed 28th August 2014.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-2917.
14. van Dam GM, Crane LM, Themelis G et al. Intraoperative tumor-speci c uorescence imaging in ovarian cancer by folate receptor- alpha targeting: rst in-human results. Nat Med 2011;Sep 18;17(10):1315-9.
15. Schaafsma BE, Mieog JS, Hutteman M et al. The clinical use of indocyanine green as a near-infrared uorescent contrast agent for image-guided oncologic surgery. J Surg Oncol 2011;104:323-332.
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, 16. Forman D. Global cancer statistics. CA Cancer
J Clin 2011;61:69-90.
4. Trimbos B, Timmers P, Pecorelli S et al. Surgical staging and treatment of early 17. ovarian cancer: long-term analysis from
a randomized trial. J Natl Cancer Inst 2010;102:982-987.
Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR e ect in macromolecular therapeutics: a review. J Control Release 2000;65:271-284.
Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986;46:6387- 6392.
5. Fader AN, Rose PG. Role of surgery in ovarian carcinoma. J Clin Oncol 2007;25:2873-2883.
18. Alacam B, Yazici B, Intes X, Nioka S, Chance B. Pharmacokinetic-rate images of indocyanine green for breast tumors using near-infrared optical methods. Phys Med Biol 2008;53:837- 859.
6. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival e ect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era:
a meta-analysis. J Clin Oncol 2002;20:1248-
1259. 19.
Hagen A, Grosenick D, Macdonald R et al. Late- uorescence mammography assesses tumor capillary permeability and di erentiates malignant from benign lesions. Opt Express 2009;17:17016-17033.
Kimura T, Muguruma N, Ito S et al. Infrared uorescence endoscopy for the diagnosis of super cial gastric tumors. Gastrointest Endosc 2007;66:37-43.
Mataki N, Nagao S, Kawaguchi A et al. Clinical usefulness of a new infrared videoendoscope system for diagnosis of early stage gastric cancer. Gastrointest Endosc 2003;57:336-342.
Ntziachristos V, Yodh AG, Schnall M, Chance B. Concurrent MRI and di use optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci U S A 2000;97:2767-2772.
Poellinger A, Burock S, Grosenick D et al. Breast cancer: early- and late- uorescence near-infrared imaging with indocyanine green--a preliminary study. Radiology 2011;258:409-416.
7. Hoskins WJ, McGuire WP, Brady MF et al. The
e ect of diameter of largest residual disease
on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet 20. Gynecol 1994;170:974-979.
8. Gri ths CT. Surgical resection of tumor
bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 21. 1975;42:101-104.
9. Colombo N, Van GT, Parma G et al. Ovarian cancer. Crit Rev Oncol Hematol 2006;60:159-
179. 22.
10. Vergote I, De W, I, Tjalma W, Van GM, Decloedt
J, van DP. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis
of 285 patients. Gynecol Oncol 1998;71:431- 23. 436.
11. Vergote I, Trimbos BJ. Treatment of patients with early epithelial ovarian cancer. Curr Opin Oncol 2003;15:452-455.
12. Vahrmeijer AL, Hutteman M, van der Vorst JR, van de Velde CJ, Frangioni JV. Image- guided cancer surgery using near-infrared uorescence. Nat Rev Clin Oncol 2013.
13. Frangioni JV. In vivo near-infrared uorescence imaging. Curr Opin Chem Biol 2003;7:626-634.
24. Kosaka N, Mitsunaga M, Longmire MR, Choyke PL, Kobayashi H. Near infrared uorescence- guided real-time endoscopic detection of peritoneal ovarian cancer nodules using intravenously injected indocyanine green. Int J Cancer 2011;129:1671-1677.
Imaging based on the EPR e ect in ovarian cancer 127